Authors: George Rajna
The researchers point out that while IMPT could potentially benefit any patient receiving radiotherapy for malignant brain tumours, paediatric patients and patients with primary CNS malignancies (who have superior survival expectations compared with patients with metastatic disease) might receive the greatest benefit.  Researchers have moved closer to the real-time verification of hadron therapy, demonstrating the in vivo accuracy of simulations that predict particle range in the patient.  A biomimetic nanosystem can deliver therapeutic proteins to selectively target cancerous tumors, according to a team of Penn State researchers.  Sunlight is essential for all life, and living organisms have evolved to sense and respond to light. 
Comments: 54 Pages.
[v1] 2019-01-22 03:52:46
Unique-IP document downloads: 10 times
Vixra.org is a pre-print repository rather than a journal. Articles hosted may not yet have been verified by peer-review and should be treated as preliminary. In particular, anything that appears to include financial or legal advice or proposed medical treatments should be treated with due caution. Vixra.org will not be responsible for any consequences of actions that result from any form of use of any documents on this website.
Add your own feedback and questions here:
You are equally welcome to be positive or negative about any paper but please be polite. If you are being critical you must mention at least one specific error, otherwise your comment will be deleted as unhelpful.